GLAXO.NSE GlaxoSmithkline Pharmaceuticals Ltd

Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. GlaxoSmithkline Pharmaceuticals Ltd market cap is 286.31B.

52 week high is the highest price of a stock in the past 52 weeks, or one year. GlaxoSmithkline Pharmaceuticals Ltd 52 week high is 1,739.75 as of December 09, 2023.

52 week low is the lowest price of a stock in the past 52 weeks, or one year. GlaxoSmithkline Pharmaceuticals Ltd 52 week low is 1,227.00 as of December 09, 2023.

GlaxoSmithkline Pharmaceuticals Ltd stock price today is 1,690.10.

GlaxoSmithkline Pharmaceuticals Ltd stock price yesterday was 1,688.85.

The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. GlaxoSmithkline Pharmaceuticals Ltd’s P/E ratio is 44.20.

The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. GlaxoSmithkline Pharmaceuticals Ltd P/B ratio is 18.5972.

EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. GlaxoSmithkline Pharmaceuticals Ltd's EBITDA is 29.55.

The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. GlaxoSmithkline Pharmaceuticals Ltd 50-day moving average is 1,545.54.

GlaxoSmithkline Pharmaceuticals Ltd has 3,680 employees.